Navigation Links
China Yongxin Pharmaceuticals Inc. Announces the Expansion of Its Chain of Retail Stores to 110 Stores
Date:7/21/2010

CHANGCHUN, China and LOS ANGELES, July 21 /PRNewswire-Asia/ -- China Yongxin Pharmaceuticals Inc. (OTC Bulletin Board: CYXN) ("China Yongxin" or the "Company"), one of the leading health products distribution and retail sales companies in China, today announced the opening of seven new chain drugstores in July. These new openings bring the Company's number of stores to 30 in Changchun City, 31 in Baishan City, and a total of 110 throughout Northeastern China. The Company has expedited the pace of store openings in order to reach its previously announced goal of opening 29 stores in 2010. The Company's objective is to become one of the top 20 pharmaceutical retail chain enterprises in China.

China Yongxin held grand opening ceremonies in July for all six new stores in Changchun City, which is expected to further increase awareness of the China Yongxin brand in the community. These six locations were chosen for their strategic locations in high density and high income residential districts. The Lin He Street store is located on the beautiful River of Life that runs through Changchun City, also known for its heavy foot traffic. The Jian Min Street store is located in the "My Home" district, adjacent to the Royal Emerald Palace upscale community. The Fei Yue Road store is located in the core of China FAW Group district, which has a large residential community with a high population density. The De Chang Road store is located in the Hongqi Street shopping district, adjacent to the Hospital of Jilin Province. The Chang Da Road and Cambridge Park stores are located near the Changchun University and Jilin University, respectively, allowing the Company to access the universities' large student populations and surrounding residents. The seventh store is located in Baishan City, adding an additional store to the Bai Shan Cao An Tang brand.

The new drugstores provide customers with a wide range of over-the-counter Chinese traditional and Western medicines, prescription pharmaceuticals, natural health products including herbal and nutritional supplements, health foods, personal care products and cosmetics. These stores will also provide customers that are located within close proximity with free delivery services, which management believes may be a cost-effective method of attracting more customers and increasing sales.

According to Mr. Yongxin Liu, Chairman and CEO, "We are pleased to announce the opening of a total of 13 new stores in 2010, expanding our footprint within densely populated and high income districts. We continue to be confident that we will reach our projected goals for 2010 and become the largest drugstore chain in Northeastern China," Mr. Yongxin Liu added.

About China Yongxin Pharmaceuticals Inc.

Founded in 1993, China Yongxin Pharmaceuticals is one of the leading retailers and distributors of over-the-counter Chinese traditional and Western medicines, prescription pharmaceuticals, natural health products including herbal and nutritional supplements, health foods, personal care products, cosmetics and medical equipment in Northeastern China. Its retail operations began in 2004, and in 2005, it gained franchise rights from one of the world's largest drug chains for China's Jilin Province.

The Company had become one of the fastest growing drug retailers in China through its retail chain of 110 drug outlets as well as its wholesale distribution in Northeastern China. For more information about China Yongxin Pharmaceuticals Inc., please visit http://www.yongxinchina.com .

Forward Looking Statements

This news release contains certain "forward-looking statements." Forward- looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. The forward-looking statements are also identified through the use of words "believe," enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict" "probable," "potential," "possible," "should," "continue," "project", "expect" and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's periodic reports filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. China Yongxin Pharmaceuticals Inc. does not assume any duty to publicly update or revise the material contained herein.

    For more information, please contact:

    CORPORATE
     China Yongxin Pharmaceuticals Inc.
     Sam Liu, Chief Operating Officer
     Tel:   +1-626-581-9098
     Email: info@yongxinchina.com

    INVESTOR RELATIONS
     Strategic Growth International, Inc.
     Richard Cooper, Chairman
     Tel:   +1-212-838-1444
     Email: rcooper@sgi-ir.com


'/>"/>
SOURCE China Yongxin Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2017)... 2017  Getinge, a leading global provider of ... and cost efficiency within healthcare and life sciences, ... practice demonstrating that intra-aortic balloon counterpulsation (IABC) appears ... patients. The single-center, retrospective, observational study showed that ... ® 50cc intra-aortic balloon (IAB) in contemporary ...
(Date:5/2/2017)... NEW YORK and ... the leading distributor of market intelligence, MarketResearch.com is pleased ... Tech Reimbursement Consulting AB that allows for the ... AB,s proprietary market analyses through the MarketResearch.com website. ... world easy access to complete product descriptions and tables ...
(Date:5/2/2017)... CORALVILLE, Iowa , May 2, 2017 /PRNewswire/ ... innovative, patient-centric radiotherapy solutions, announced today that ... has been with CIVCO since 2012 and has ... line management, senior vice president and general manager, ... manager. "I am extremely proud of ...
Breaking Medicine Technology:
(Date:5/24/2017)... ... May 24, 2017 , ... ... ExtraHop to its solutions portfolio. ExtraHop delivers an analytics-first approach, layered with machine ... IT system, from the datacenter to the cloud to the edge. Through the ...
(Date:5/24/2017)... Massapequa Park, NY (PRWEB) , ... May 24, ... ... today announced the practice is offering holistic pediatric dentistry options for its patients ... the context of the patient’s entire physical well being, and is one of ...
(Date:5/24/2017)... Chicago, IL (PRWEB) , ... May 24, 2017 ... ... of the most prominent for-profit and nonprofit hospitals and health systems in the ... have turned around their institutions, led professional organizations and been instrumental in developing ...
(Date:5/24/2017)... West Orange, NJ (PRWEB) , ... May 24, 2017 , ... ... ingredients for avoiding back injury when either lifting weights for strength training and exercise ... Atlantic Spine Center . , “Body position is everything,” Dr. Chang says. “Improper ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... Population Health and Clinical Integration company, announced today that its iClinic V12.2 solution ... (PCMH) 2017 Prevalidation. NCQA recently introduced PCMH 2017 standards which emphasize team-based ...
Breaking Medicine News(10 mins):